Ono Pharmaceutical Co., Ltd.:企業の戦略・SWOT・財務分析

◆英語タイトル:Ono Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4785
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,200見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥54,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Ono Pharmaceutical Co., Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

Ono Pharmaceutical Co., Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Ono Pharmaceutical (Ono or ‘the company’) is a pharmaceutical company that manufactures and sells pharmaceuticals and diagnostic reagents with focus on prescription pharmaceuticals. The company offers products in various forms such as capsules, tablets, injections, patches, dry syrup and intravenous infusion. It markets pharmaceuticals under Opdivo, Glactiv, Forxiga, Kinedak, Recalbon, Parsabiv, Rivastach, Onoact, Staybla, Opalmon, Onon, Staybla, Orencia and Foipan brand names. It offers these products for the treatment of chronic pancreatitis, postoperative reflux esophagitis, type 2 diabetes, peripheral circulatory disorder, overactive bladder, osteoporosis, bronchial asthma, Alzheimer’s disease, rheumatoid arthritis and allergic rhinitis, among others. The company operates in Japan, other Asian countries, Europe and the US. Ono is headquartered in Chuo-ku, Osaka, Japan.

Scope

- Detailed information on Ono Pharmaceutical Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ono Pharmaceutical Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Ono Pharmaceutical Co., Ltd. including a breakdown and examination of key business segments
- Intelligence on Ono Pharmaceutical Co., Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ono Pharmaceutical Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Ono Pharmaceutical Co., Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ono Pharmaceutical Co., Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Ono Pharmaceutical Co., Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Ono Pharmaceutical Co., Ltd.: Company Overview
Ono Pharmaceutical Co., Ltd.: Overview and Key Facts
Ono Pharmaceutical Co., Ltd.: Overview
Ono Pharmaceutical Co., Ltd.: Key Facts
Ono Pharmaceutical Co., Ltd.: Key Employees
Ono Pharmaceutical Co., Ltd.: Key Employee Biographies
Ono Pharmaceutical Co., Ltd.: Major Products and Services
Ono Pharmaceutical Co., Ltd.: Company History
Ono Pharmaceutical Co., Ltd.: Management Statement
Ono Pharmaceutical Co., Ltd.: Locations and Subsidiaries
Ono Pharmaceutical Co., Ltd.: Key Competitors
Ono Pharmaceutical Co., Ltd.: Company Analysis
Ono Pharmaceutical Co., Ltd.: Business Description
Ono Pharmaceutical Co., Ltd.: SWOT Analysis
Ono Pharmaceutical Co., Ltd.: SWOT Overview
Ono Pharmaceutical Co., Ltd.: Strengths
Ono Pharmaceutical Co., Ltd.: Weaknesses
Ono Pharmaceutical Co., Ltd.: Opportunities
Ono Pharmaceutical Co., Ltd.: Threats
Ono Pharmaceutical Co., Ltd.: Corporate Financial Deals Activity
Ono Pharmaceutical Co., Ltd.: Financial Deals Overview
Ono Pharmaceutical Co., Ltd.: Targets and Partners
Ono Pharmaceutical Co., Ltd.: Top Deals 2016 – 2020YTD*
Ono Pharmaceutical Co., Ltd.: Partnership
Ono Pharmaceutical Co., Ltd.: Divestments
Ono Pharmaceutical Co., Ltd.: Recent Developments
Ono Pharmaceutical Co., Ltd.: News and Events Summary
Ono Pharmaceutical Co., Ltd.: Business Expansion
Ono Pharmaceutical Co., Ltd.: Contracts
Ono Pharmaceutical Co., Ltd.: Corporate Governance
Ono Pharmaceutical Co., Ltd.: Corporate Social Responsibility
Ono Pharmaceutical Co., Ltd.: Financial Deals
Ono Pharmaceutical Co., Ltd.: Financial Performance
Ono Pharmaceutical Co., Ltd.: Regulatory and Legal Events
Ono Pharmaceutical Co., Ltd.: Research & Development
Ono Pharmaceutical Co., Ltd.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Ono Pharmaceutical Co., Ltd.: Key Facts
Table 2: Ono Pharmaceutical Co., Ltd.: Key Employees
Table 3: Ono Pharmaceutical Co., Ltd.: Company History
Table 4: Ono Pharmaceutical Co., Ltd.: Locations and Subsidiaries
Table 5: Ono Pharmaceutical Co., Ltd.: Key Competitors
Table 6: Ono Pharmaceutical Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Ono Pharmaceutical Co., Ltd.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Ono Pharmaceutical Co., Ltd.: Targets and Partners
Table 9: Ono Pharmaceutical Co., Ltd.: Top Deals 2016 - 2020YTD*
Table 10: Ono Pharmaceutical Co., Ltd.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 11: Ono Pharmaceutical Co., Ltd.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 12: Ono Pharmaceutical Co., Ltd.: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 13: Ono Pharmaceutical Co., Ltd.: News and Events Summary
Table 14: Ono Pharmaceutical Co., Ltd.: Business Expansion
Table 15: Ono Pharmaceutical Co., Ltd.: Contracts
Table 16: Ono Pharmaceutical Co., Ltd.: Corporate Governance
Table 17: Ono Pharmaceutical Co., Ltd.: Corporate Social Responsibility
Table 18: Ono Pharmaceutical Co., Ltd.: Financial Deals
Table 19: Ono Pharmaceutical Co., Ltd.: Financial Performance
Table 20: Ono Pharmaceutical Co., Ltd.: Regulatory and Legal Events
Table 21: Ono Pharmaceutical Co., Ltd.: Research & Development
Table 22: Ono Pharmaceutical Co., Ltd.: Strategy and Operations

★海外企業調査レポート[Ono Pharmaceutical Co., Ltd.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Harvard Medical School:企業のM&A・事業提携・投資動向
    Harvard Medical School - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Harvard Medical School Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • DHL Supply Chain:企業の戦略・SWOT・財務分析
    DHL Supply Chain - Strategy, SWOT and Corporate Finance Report Summary DHL Supply Chain - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • ViaCyte Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ViaCyte Inc (ViaCyte), formerly Novocell Inc is a regenerative medicine company that centres on the development of cell replacement therapies for the treatment of diabetes. The company’s pipeline products portfolio includes VC-01, which is being developed as a therapy for T1D patients who ha …
  • Gilead Sciences Inc (GILD):医療機器:M&Aディール及び事業提携情報
    Summary Gilead Sciences Inc (Gilead) is a research-based biopharmaceutical company. It focuses on the discovery, development and commercialization of medicines for the treatment of cardiovascular, hematological and respiratory diseases, inflammation, liver diseases, cancer and human immunodeficiency …
  • Cherry Rocher Neyret Chavin SA:企業の戦略・SWOT・財務情報
    Cherry Rocher Neyret Chavin SA - Strategy, SWOT and Corporate Finance Report Summary Cherry Rocher Neyret Chavin SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • University of Leeds:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Leeds (University of Leeds) is an educational university that offers academic programs. The university offers undergraduate, post graduate, research degrees, online and distance learning educational programs. It offers education programs in the areas of arts, biological science …
  • PJSC Detsky Mir (DSKY):企業の財務・戦略的SWOT分析
    PJSC Detsky Mir (DSKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Alexion Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析
    Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Actinium Pharmaceuticals Inc (ATNM):企業の財務・戦略的SWOT分析
    Summary Actinium Pharmaceuticals Inc (ATNM), formerly Cactus Ventures Inc is a biopharmaceutical company that provides development of cancer immunotherapies. The company provides pipeline products such as Iomab-B that is used for hematopoietic stem cells transplantation. It provides Iomab-B through …
  • Tonix Pharmaceuticals Holding Corp (TNXP):企業の財務・戦略的SWOT分析
    Summary Tonix Pharmaceuticals Holding Corp (Tonix) is a developer of pharmaceutical products to address public health challenges. The company offers pharmaceutical products and treatments for disorders of the central nervous system including fibromyalgia, post traumatic stress disorder and episodic …
  • Pear Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD) in conjunction with opioid replacement therapy; Thrive …
  • DHX Media Ltd.:企業のM&A・事業提携・投資動向
    DHX Media Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DHX Media Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • PizzaExpress Limited:企業の戦略・SWOT・財務情報
    PizzaExpress Limited - Strategy, SWOT and Corporate Finance Report Summary PizzaExpress Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SVB Financial Group:企業の戦略・SWOT・財務情報
    SVB Financial Group - Strategy, SWOT and Corporate Finance Report Summary SVB Financial Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • IFA Hotels and Resorts Company KSCC:企業の戦略・SWOT・財務情報
    IFA Hotels and Resorts Company KSCC - Strategy, SWOT and Corporate Finance Report Summary IFA Hotels and Resorts Company KSCC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Cleco Corporate Holdings LLC:企業の発電所・SWOT分析2018
    Cleco Corporate Holdings LLC - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Islami Bank Bangladesh Ltd:企業の戦略・SWOT・財務分析
    Islami Bank Bangladesh Ltd - Strategy, SWOT and Corporate Finance Report Summary Islami Bank Bangladesh Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • AdvanDx Inc:医療機器:M&Aディール及び事業提携情報
    Summary AdvanDx Inc (AdvanDx), a subsidiary of OpGen Inc is a healthcare solution provider that offers rapid and accurate molecular diagnostic tests for identification of pathogens causing critical infections in hospitalized patients. The company operates molecular testing of positive blood cultures …
  • The Kansai Electric Power Co Inc (9503):電力:M&Aディール及び事業提携情報
    Summary The Kansai Electric Power Co Inc (KEPCo) is an integrated power utility. It produces and supplies electricity and thermal energy; and procures and sells natural gas. The company generates electricity using natural gas, nuclear, coal, oil, wind, hydro, and solar sources. Through long, medium, …
  • Aeroflot Oao
    Aeroflot Oao - Strategy, SWOT and Corporate Finance Report Summary Aeroflot Oao - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆